

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | adult feeding behavior (GO:0008343) | 9.59799559 |
| 2 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 8.55281378 |
| 3 | regulation of acrosome reaction (GO:0060046) | 7.97202976 |
| 4 | regulation of protein glycosylation (GO:0060049) | 7.71258543 |
| 5 | positive regulation of cAMP-mediated signaling (GO:0043950) | 7.54651855 |
| 6 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 7.18303331 |
| 7 | sphingosine metabolic process (GO:0006670) | 6.97979614 |
| 8 | piRNA metabolic process (GO:0034587) | 6.75480522 |
| 9 | thrombin receptor signaling pathway (GO:0070493) | 6.42553817 |
| 10 | glycerol ether metabolic process (GO:0006662) | 6.36439912 |
| 11 | diol metabolic process (GO:0034311) | 6.28721424 |
| 12 | sphingoid metabolic process (GO:0046519) | 5.98437644 |
| 13 | ether metabolic process (GO:0018904) | 5.87452334 |
| 14 | DNA replication-dependent nucleosome assembly (GO:0006335) | 5.71115359 |
| 15 | DNA replication-dependent nucleosome organization (GO:0034723) | 5.71115359 |
| 16 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 5.47803609 |
| 17 | notochord development (GO:0030903) | 5.44142580 |
| 18 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 5.12334739 |
| 19 | ncRNA catabolic process (GO:0034661) | 5.00168559 |
| 20 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.96438908 |
| 21 | cellular response to ammonium ion (GO:0071242) | 4.90420241 |
| 22 | mRNA cleavage (GO:0006379) | 4.89425468 |
| 23 | regulation of cAMP-mediated signaling (GO:0043949) | 4.79577504 |
| 24 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 4.71977424 |
| 25 | signal complex assembly (GO:0007172) | 4.45623262 |
| 26 | pyrimidine dimer repair (GO:0006290) | 4.40284405 |
| 27 | cellular response to alkaloid (GO:0071312) | 4.36798408 |
| 28 | N-terminal protein amino acid acetylation (GO:0006474) | 3.95281586 |
| 29 | negative regulation of glycoprotein metabolic process (GO:1903019) | 3.90205561 |
| 30 | vitamin catabolic process (GO:0009111) | 3.86497864 |
| 31 | fat-soluble vitamin catabolic process (GO:0042363) | 3.86497864 |
| 32 | coenzyme catabolic process (GO:0009109) | 3.83097767 |
| 33 | negative regulation of adenylate cyclase activity (GO:0007194) | 3.79699048 |
| 34 | regulation of female receptivity (GO:0045924) | 3.74443696 |
| 35 | regulation of translational elongation (GO:0006448) | 3.73806053 |
| 36 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 3.66754117 |
| 37 | glomerular visceral epithelial cell development (GO:0072015) | 3.66462828 |
| 38 | negative regulation of cyclase activity (GO:0031280) | 3.60032034 |
| 39 | negative regulation of lyase activity (GO:0051350) | 3.53947943 |
| 40 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.52741826 |
| 41 | signal peptide processing (GO:0006465) | 3.52627020 |
| 42 | response to morphine (GO:0043278) | 3.49941128 |
| 43 | negative regulation of cell-matrix adhesion (GO:0001953) | 3.49863526 |
| 44 | negative regulation of exocytosis (GO:0045920) | 3.46543594 |
| 45 | cornea development in camera-type eye (GO:0061303) | 3.43355956 |
| 46 | response to isoquinoline alkaloid (GO:0014072) | 3.40434344 |
| 47 | replication fork processing (GO:0031297) | 3.37319348 |
| 48 | female mating behavior (GO:0060180) | 3.36170317 |
| 49 | glycosphingolipid metabolic process (GO:0006687) | 3.35684937 |
| 50 | detection of chemical stimulus involved in sensory perception of smell (GO:0050911) | 3.35471954 |
| 51 | DNA deamination (GO:0045006) | 3.30466685 |
| 52 | omega-hydroxylase P450 pathway (GO:0097267) | 3.29936081 |
| 53 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 3.24018049 |
| 54 | glomerular epithelial cell development (GO:0072310) | 3.18297946 |
| 55 | thyroid hormone generation (GO:0006590) | 3.18133165 |
| 56 | positive regulation of fatty acid transport (GO:2000193) | 3.09917507 |
| 57 | positive regulation of icosanoid secretion (GO:0032305) | 3.09086097 |
| 58 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.08589054 |
| 59 | neuronal action potential (GO:0019228) | 3.06185340 |
| 60 | ribonucleoprotein complex disassembly (GO:0032988) | 3.03737370 |
| 61 | thyroid hormone metabolic process (GO:0042403) | 2.96120421 |
| 62 | regulation of odontogenesis (GO:0042481) | 2.95446475 |
| 63 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 2.89474091 |
| 64 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.85128001 |
| 65 | glycolipid metabolic process (GO:0006664) | 2.84682235 |
| 66 | DNA synthesis involved in DNA repair (GO:0000731) | 2.84052127 |
| 67 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 2.80727251 |
| 68 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.79971183 |
| 69 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.79778121 |
| 70 | detection of light stimulus involved in visual perception (GO:0050908) | 2.79778121 |
| 71 | urate metabolic process (GO:0046415) | 2.78792614 |
| 72 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.77028347 |
| 73 | membrane lipid metabolic process (GO:0006643) | 2.75915192 |
| 74 | wound healing, spreading of epidermal cells (GO:0035313) | 2.74872778 |
| 75 | response to caffeine (GO:0031000) | 2.74798989 |
| 76 | gene silencing by RNA (GO:0031047) | 2.74702687 |
| 77 | regulation of memory T cell differentiation (GO:0043380) | 2.74052267 |
| 78 | quinone biosynthetic process (GO:1901663) | 2.73856097 |
| 79 | cell-cell junction maintenance (GO:0045217) | 2.72281421 |
| 80 | negative regulation of cAMP biosynthetic process (GO:0030818) | 2.70523383 |
| 81 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.69843602 |
| 82 | left/right axis specification (GO:0070986) | 2.68688114 |
| 83 | liposaccharide metabolic process (GO:1903509) | 2.67656420 |
| 84 | membrane depolarization during action potential (GO:0086010) | 2.66777970 |
| 85 | spermatid development (GO:0007286) | 2.66451592 |
| 86 | glomerular basement membrane development (GO:0032836) | 2.65905413 |
| 87 | sensory perception of pain (GO:0019233) | 2.61928022 |
| 88 | resolution of meiotic recombination intermediates (GO:0000712) | 2.61304926 |
| 89 | dopamine receptor signaling pathway (GO:0007212) | 2.61012377 |
| 90 | negative regulation of cyclic nucleotide biosynthetic process (GO:0030803) | 2.59184862 |
| 91 | maintenance of fidelity involved in DNA-dependent DNA replication (GO:0045005) | 2.56275895 |
| 92 | transmission of nerve impulse (GO:0019226) | 2.53733457 |
| 93 | indolalkylamine metabolic process (GO:0006586) | 2.53502044 |
| 94 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 14.9988661 |
| 95 | negative regulation of cAMP-mediated signaling (GO:0043951) | 12.7685296 |
| 96 | opioid receptor signaling pathway (GO:0038003) | 11.2119165 |
| 97 | ether lipid metabolic process (GO:0046485) | 10.7349891 |
| 98 | regulation of translational termination (GO:0006449) | 10.1871984 |
| 99 | behavioral response to ethanol (GO:0048149) | 10.0366391 |
| 100 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 10.0290142 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 4.43514418 |
| 2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.22630105 |
| 3 | VDR_22108803_ChIP-Seq_LS180_Human | 3.83963988 |
| 4 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 3.80740240 |
| 5 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 3.79201699 |
| 6 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 2.94879381 |
| 7 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.94879381 |
| 8 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.74997824 |
| 9 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.55067665 |
| 10 | RXR_22108803_ChIP-Seq_LS180_Human | 2.50839918 |
| 11 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.47458434 |
| 12 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.19412506 |
| 13 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.17928956 |
| 14 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.16535368 |
| 15 | NANOG_19829295_ChIP-Seq_ESCs_Human | 2.13502285 |
| 16 | SOX2_19829295_ChIP-Seq_ESCs_Human | 2.13502285 |
| 17 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.12675346 |
| 18 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 2.07053877 |
| 19 | EGR1_19032775_ChIP-ChIP_M12_Human | 2.04085827 |
| 20 | BCAT_22108803_ChIP-Seq_LS180_Human | 2.03270844 |
| 21 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.02829133 |
| 22 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.95819974 |
| 23 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.89686547 |
| 24 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.88265838 |
| 25 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.86191088 |
| 26 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.86191088 |
| 27 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.85150652 |
| 28 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.83133673 |
| 29 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.81503219 |
| 30 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.77606973 |
| 31 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.74485111 |
| 32 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.70885182 |
| 33 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.66067673 |
| 34 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.65975045 |
| 35 | TCF4_23295773_ChIP-Seq_U87_Human | 1.62490818 |
| 36 | STAT3_23295773_ChIP-Seq_U87_Human | 1.57045519 |
| 37 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.55631710 |
| 38 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.52913024 |
| 39 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.51451428 |
| 40 | P300_19829295_ChIP-Seq_ESCs_Human | 1.51214795 |
| 41 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.46516314 |
| 42 | FUS_26573619_Chip-Seq_HEK293_Human | 1.42665385 |
| 43 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.41104733 |
| 44 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.39781668 |
| 45 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.37706595 |
| 46 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.35584666 |
| 47 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.35413543 |
| 48 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.35286885 |
| 49 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.34551477 |
| 50 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.34214693 |
| 51 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.31262538 |
| 52 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 1.30981158 |
| 53 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.24788776 |
| 54 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.24198449 |
| 55 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.21752161 |
| 56 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.18861598 |
| 57 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.16961770 |
| 58 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.15235626 |
| 59 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.13828435 |
| 60 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.13559581 |
| 61 | AR_25329375_ChIP-Seq_VCAP_Human | 1.12816037 |
| 62 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.11984843 |
| 63 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.11442425 |
| 64 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.11376017 |
| 65 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.11150694 |
| 66 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.10719164 |
| 67 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.09838230 |
| 68 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.08963133 |
| 69 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.08066580 |
| 70 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.07601960 |
| 71 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.07470413 |
| 72 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.06771976 |
| 73 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.05935469 |
| 74 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.05810380 |
| 75 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.05516804 |
| 76 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.05284785 |
| 77 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.05227612 |
| 78 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.03772591 |
| 79 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.03599649 |
| 80 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.02042209 |
| 81 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.01138764 |
| 82 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.00957004 |
| 83 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.99637802 |
| 84 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.98765069 |
| 85 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.98508461 |
| 86 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.98108013 |
| 87 | EWS_26573619_Chip-Seq_HEK293_Human | 0.97598682 |
| 88 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.97015049 |
| 89 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.96893147 |
| 90 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.96631856 |
| 91 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.94593386 |
| 92 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.93731770 |
| 93 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93698541 |
| 94 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.92999272 |
| 95 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.91428245 |
| 96 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.91422070 |
| 97 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.91278226 |
| 98 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.91092963 |
| 99 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.90813736 |
| 100 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90766481 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009278_abnormal_bone_marrow | 6.33659318 |
| 2 | MP0002876_abnormal_thyroid_physiology | 5.93176557 |
| 3 | MP0009780_abnormal_chondrocyte_physiolo | 5.56936027 |
| 4 | MP0001968_abnormal_touch/_nociception | 4.41482411 |
| 5 | MP0003880_abnormal_central_pattern | 4.38953260 |
| 6 | MP0005503_abnormal_tendon_morphology | 3.85884407 |
| 7 | MP0005360_urolithiasis | 3.76830163 |
| 8 | MP0003941_abnormal_skin_development | 3.18372639 |
| 9 | MP0000678_abnormal_parathyroid_gland | 2.84645812 |
| 10 | MP0009764_decreased_sensitivity_to | 2.75869015 |
| 11 | MP0008057_abnormal_DNA_replication | 2.73322293 |
| 12 | MP0005551_abnormal_eye_electrophysiolog | 2.45252838 |
| 13 | MP0006035_abnormal_mitochondrial_morpho | 2.42457822 |
| 14 | MP0001501_abnormal_sleep_pattern | 2.23449855 |
| 15 | MP0005646_abnormal_pituitary_gland | 2.23349718 |
| 16 | MP0003183_abnormal_peptide_metabolism | 2.21412474 |
| 17 | MP0000681_abnormal_thyroid_gland | 2.19872993 |
| 18 | MP0001545_abnormal_hematopoietic_system | 2.19439851 |
| 19 | MP0005397_hematopoietic_system_phenotyp | 2.19439851 |
| 20 | MP0003045_fibrosis | 1.92235558 |
| 21 | MP0009333_abnormal_splenocyte_physiolog | 1.91669420 |
| 22 | MP0003950_abnormal_plasma_membrane | 1.88207708 |
| 23 | MP0001664_abnormal_digestion | 1.83192877 |
| 24 | MP0003195_calcinosis | 1.76100808 |
| 25 | MP0004147_increased_porphyrin_level | 1.75150762 |
| 26 | MP0002733_abnormal_thermal_nociception | 1.74944107 |
| 27 | MP0003567_abnormal_fetal_cardiomyocyte | 1.72104418 |
| 28 | MP0005645_abnormal_hypothalamus_physiol | 1.55076642 |
| 29 | MP0003633_abnormal_nervous_system | 1.53289056 |
| 30 | MP0003638_abnormal_response/metabolism_ | 1.49956229 |
| 31 | MP0009046_muscle_twitch | 1.43422837 |
| 32 | MP0003191_abnormal_cellular_cholesterol | 1.42405832 |
| 33 | MP0004782_abnormal_surfactant_physiolog | 1.41782120 |
| 34 | MP0003646_muscle_fatigue | 1.37303648 |
| 35 | MP0002249_abnormal_larynx_morphology | 1.36320313 |
| 36 | MP0009745_abnormal_behavioral_response | 1.32418179 |
| 37 | MP0003879_abnormal_hair_cell | 1.32367593 |
| 38 | MP0002272_abnormal_nervous_system | 1.26846153 |
| 39 | MP0003959_abnormal_lean_body | 1.14761615 |
| 40 | MP0001970_abnormal_pain_threshold | 1.10639628 |
| 41 | MP0009765_abnormal_xenobiotic_induced | 1.05004960 |
| 42 | MP0001486_abnormal_startle_reflex | 1.03100441 |
| 43 | MP0002971_abnormal_brown_adipose | 1.01864554 |
| 44 | MP0005167_abnormal_blood-brain_barrier | 1.00114793 |
| 45 | MP0002148_abnormal_hypersensitivity_rea | 0.98379262 |
| 46 | MP0000230_abnormal_systemic_arterial | 0.98261528 |
| 47 | MP0002796_impaired_skin_barrier | 0.98162574 |
| 48 | MP0008775_abnormal_heart_ventricle | 0.97035928 |
| 49 | MP0001881_abnormal_mammary_gland | 0.95742528 |
| 50 | MP0008872_abnormal_physiological_respon | 0.94075445 |
| 51 | MP0000749_muscle_degeneration | 0.91926722 |
| 52 | MP0006276_abnormal_autonomic_nervous | 0.86776892 |
| 53 | MP0003631_nervous_system_phenotype | 0.85057152 |
| 54 | MP0001919_abnormal_reproductive_system | 0.84334891 |
| 55 | MP0000015_abnormal_ear_pigmentation | 0.81694141 |
| 56 | MP0005195_abnormal_posterior_eye | 0.79420727 |
| 57 | MP0003937_abnormal_limbs/digits/tail_de | 0.78015325 |
| 58 | MP0004858_abnormal_nervous_system | 0.76034009 |
| 59 | MP0010234_abnormal_vibrissa_follicle | 0.73622903 |
| 60 | MP0005083_abnormal_biliary_tract | 0.72488229 |
| 61 | MP0000358_abnormal_cell_content/ | 0.71557779 |
| 62 | MP0010771_integument_phenotype | 0.71372416 |
| 63 | MP0002168_other_aberrant_phenotype | 0.71356767 |
| 64 | MP0005334_abnormal_fat_pad | 0.71333226 |
| 65 | MP0005670_abnormal_white_adipose | 0.70518750 |
| 66 | MP0001485_abnormal_pinna_reflex | 0.67730894 |
| 67 | MP0002693_abnormal_pancreas_physiology | 0.66405678 |
| 68 | MP0003868_abnormal_feces_composition | 0.65687752 |
| 69 | MP0003136_yellow_coat_color | 0.63884067 |
| 70 | MP0002229_neurodegeneration | 0.63425096 |
| 71 | MP0002108_abnormal_muscle_morphology | 0.62329046 |
| 72 | MP0002736_abnormal_nociception_after | 0.62258903 |
| 73 | MP0000049_abnormal_middle_ear | 0.62139631 |
| 74 | MP0005389_reproductive_system_phenotype | 0.62040587 |
| 75 | MP0004130_abnormal_muscle_cell | 0.61316571 |
| 76 | MP0003936_abnormal_reproductive_system | 0.59221327 |
| 77 | MP0009672_abnormal_birth_weight | 0.59125059 |
| 78 | MP0006072_abnormal_retinal_apoptosis | 0.58069186 |
| 79 | MP0004085_abnormal_heartbeat | 0.57974413 |
| 80 | MP0004043_abnormal_pH_regulation | 0.56701926 |
| 81 | MP0001324_abnormal_eye_pigmentation | 0.56513958 |
| 82 | MP0005310_abnormal_salivary_gland | 0.55809361 |
| 83 | MP0005501_abnormal_skin_physiology | 0.52752809 |
| 84 | MP0001270_distended_abdomen | 0.52157570 |
| 85 | MP0001986_abnormal_taste_sensitivity | 0.51159497 |
| 86 | MP0008874_decreased_physiological_sensi | 0.50777112 |
| 87 | MP0002557_abnormal_social/conspecific_i | 0.50574759 |
| 88 | MP0001929_abnormal_gametogenesis | 0.50365812 |
| 89 | MP0001963_abnormal_hearing_physiology | 0.50332306 |
| 90 | MP0005085_abnormal_gallbladder_physiolo | 0.49907417 |
| 91 | MP0005452_abnormal_adipose_tissue | 0.49516221 |
| 92 | MP0002067_abnormal_sensory_capabilities | 0.49345721 |
| 93 | MP0009384_cardiac_valve_regurgitation | 0.49192259 |
| 94 | MP0008875_abnormal_xenobiotic_pharmacok | 0.48527039 |
| 95 | MP0002069_abnormal_eating/drinking_beha | 0.48316001 |
| 96 | MP0002572_abnormal_emotion/affect_behav | 0.46481013 |
| 97 | MP0000778_abnormal_nervous_system | 0.46335926 |
| 98 | MP0002064_seizures | 0.45056617 |
| 99 | MP0003718_maternal_effect | 0.44795823 |
| 100 | MP0003635_abnormal_synaptic_transmissio | 0.44741375 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Volvulus (HP:0002580) | 7.48326465 |
| 2 | Intestinal atresia (HP:0011100) | 6.95920567 |
| 3 | Pancreatic islet-cell hyperplasia (HP:0004510) | 6.38737092 |
| 4 | Abnormality of the aortic arch (HP:0012303) | 5.76608229 |
| 5 | Large for gestational age (HP:0001520) | 5.76006864 |
| 6 | Broad alveolar ridges (HP:0000187) | 5.48821926 |
| 7 | Thickened helices (HP:0000391) | 4.96257105 |
| 8 | Poor head control (HP:0002421) | 4.61277096 |
| 9 | Oligodontia (HP:0000677) | 4.57815198 |
| 10 | Mesangial abnormality (HP:0001966) | 4.36596265 |
| 11 | Gaze-evoked nystagmus (HP:0000640) | 4.34867381 |
| 12 | Focal motor seizures (HP:0011153) | 4.05079745 |
| 13 | Abnormality of the ileum (HP:0001549) | 4.04104786 |
| 14 | Abnormality of the pancreatic islet cells (HP:0006476) | 4.00620326 |
| 15 | Abnormality of endocrine pancreas physiology (HP:0012093) | 4.00620326 |
| 16 | Agitation (HP:0000713) | 3.93134462 |
| 17 | Congenital ichthyosiform erythroderma (HP:0007431) | 3.89912948 |
| 18 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.72576756 |
| 19 | Gastrointestinal atresia (HP:0002589) | 3.64118718 |
| 20 | Hypoproteinemia (HP:0003075) | 3.50782985 |
| 21 | Chromsome breakage (HP:0040012) | 3.26349766 |
| 22 | Tubular atrophy (HP:0000092) | 3.11723108 |
| 23 | Tented upper lip vermilion (HP:0010804) | 3.06697979 |
| 24 | Cerebellar dysplasia (HP:0007033) | 2.99005087 |
| 25 | Large eyes (HP:0001090) | 2.92095550 |
| 26 | Progressive inability to walk (HP:0002505) | 2.89591907 |
| 27 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.84929706 |
| 28 | Type II lissencephaly (HP:0007260) | 2.82648622 |
| 29 | Abnormality of the alveolar ridges (HP:0006477) | 2.75368043 |
| 30 | Myositis (HP:0100614) | 2.73307081 |
| 31 | Broad-based gait (HP:0002136) | 2.71822868 |
| 32 | Optic nerve hypoplasia (HP:0000609) | 2.71065855 |
| 33 | Embryonal renal neoplasm (HP:0011794) | 2.70674916 |
| 34 | Pili torti (HP:0003777) | 2.65275270 |
| 35 | Poor speech (HP:0002465) | 2.62839264 |
| 36 | Abnormality of macular pigmentation (HP:0008002) | 2.56993588 |
| 37 | Orchitis (HP:0100796) | 2.54029823 |
| 38 | Hyperpituitarism (HP:0010514) | 2.53346324 |
| 39 | Neonatal respiratory distress (HP:0002643) | 2.48141062 |
| 40 | 3-Methylglutaconic aciduria (HP:0003535) | 2.46441840 |
| 41 | Long nose (HP:0003189) | 2.41247410 |
| 42 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.36786634 |
| 43 | Abnormal hair laboratory examination (HP:0003328) | 2.32113305 |
| 44 | Pigmentary retinal degeneration (HP:0001146) | 2.27220460 |
| 45 | Entropion (HP:0000621) | 2.26610018 |
| 46 | Impulsivity (HP:0100710) | 2.26480955 |
| 47 | Ectropion (HP:0000656) | 2.25095992 |
| 48 | High anterior hairline (HP:0009890) | 2.20198617 |
| 49 | Abnormality of the pons (HP:0007361) | 2.19460585 |
| 50 | Hyperthyroidism (HP:0000836) | 2.18616529 |
| 51 | Dysdiadochokinesis (HP:0002075) | 2.18446810 |
| 52 | Central scotoma (HP:0000603) | 2.18166337 |
| 53 | Lissencephaly (HP:0001339) | 2.16774848 |
| 54 | Hypoplasia of the pons (HP:0012110) | 2.16026553 |
| 55 | Dialeptic seizures (HP:0011146) | 2.13858353 |
| 56 | Restlessness (HP:0000711) | 2.12557476 |
| 57 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.11875952 |
| 58 | Goiter (HP:0000853) | 2.11754852 |
| 59 | Autoimmune hemolytic anemia (HP:0001890) | 2.09079865 |
| 60 | Congenital stationary night blindness (HP:0007642) | 2.07929521 |
| 61 | Amelogenesis imperfecta (HP:0000705) | 2.06630253 |
| 62 | Focal seizures (HP:0007359) | 2.04901871 |
| 63 | Pendular nystagmus (HP:0012043) | 2.03460312 |
| 64 | Attenuation of retinal blood vessels (HP:0007843) | 2.02132434 |
| 65 | Hypoplasia of the brainstem (HP:0002365) | 2.00658204 |
| 66 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.00658204 |
| 67 | Thyroid-stimulating hormone excess (HP:0002925) | 13.3755768 |
| 68 | Duplicated collecting system (HP:0000081) | 1.99433622 |
| 69 | Increased corneal curvature (HP:0100692) | 1.97133866 |
| 70 | Keratoconus (HP:0000563) | 1.97133866 |
| 71 | Nonprogressive disorder (HP:0003680) | 1.95528495 |
| 72 | Generalized tonic-clonic seizures (HP:0002069) | 1.94860402 |
| 73 | Hypohidrosis (HP:0000966) | 1.92574632 |
| 74 | Ileus (HP:0002595) | 1.91896791 |
| 75 | Scotoma (HP:0000575) | 1.87500996 |
| 76 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.87184231 |
| 77 | Abnormality of the vitreous humor (HP:0004327) | 1.84512374 |
| 78 | Inability to walk (HP:0002540) | 1.82422621 |
| 79 | Abnormality of the renal collecting system (HP:0004742) | 1.82249403 |
| 80 | Severe visual impairment (HP:0001141) | 1.82197163 |
| 81 | Muscular dystrophy (HP:0003560) | 1.80767089 |
| 82 | Poikiloderma (HP:0001029) | 1.78617052 |
| 83 | Facial diplegia (HP:0001349) | 1.76504202 |
| 84 | Striae distensae (HP:0001065) | 1.75374919 |
| 85 | Abolished electroretinogram (ERG) (HP:0000550) | 1.72874363 |
| 86 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.71194609 |
| 87 | Pancreatic cysts (HP:0001737) | 1.68702201 |
| 88 | Episodic fever (HP:0001954) | 1.68453488 |
| 89 | Cutaneous melanoma (HP:0012056) | 1.65367761 |
| 90 | Aplasia/Hypoplasia affecting the fundus (HP:0008057) | 1.64584639 |
| 91 | Abnormality of proline metabolism (HP:0010907) | 1.62960961 |
| 92 | Hydroxyprolinuria (HP:0003080) | 1.62960961 |
| 93 | Lack of skin elasticity (HP:0100679) | 1.62702329 |
| 94 | Ketoacidosis (HP:0001993) | 1.61688146 |
| 95 | Hyperglycinuria (HP:0003108) | 1.60711469 |
| 96 | Abnormality of the columella (HP:0009929) | 1.57849274 |
| 97 | Pancreatic fibrosis (HP:0100732) | 1.56180305 |
| 98 | Non-midline cleft lip (HP:0100335) | 1.55824701 |
| 99 | Meckel diverticulum (HP:0002245) | 1.54705773 |
| 100 | Severe muscular hypotonia (HP:0006829) | 1.52794620 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 5.38173416 |
| 2 | ERN1 | 3.94735490 |
| 3 | PINK1 | 3.68612561 |
| 4 | PDK2 | 3.07122869 |
| 5 | IRAK3 | 2.65240650 |
| 6 | PNCK | 2.61067655 |
| 7 | ADRBK1 | 2.58970686 |
| 8 | TIE1 | 2.10680452 |
| 9 | ADRBK2 | 10.3895124 |
| 10 | BMPR1B | 1.85063017 |
| 11 | PRKCG | 1.82919194 |
| 12 | DYRK3 | 1.80742256 |
| 13 | TGFBR1 | 1.77967810 |
| 14 | GRK1 | 1.75331105 |
| 15 | PRKCE | 1.66612846 |
| 16 | ACVR1B | 1.62323616 |
| 17 | ZAK | 1.56050853 |
| 18 | CLK1 | 1.35325052 |
| 19 | TYRO3 | 1.34712236 |
| 20 | EIF2AK3 | 1.26765251 |
| 21 | PLK2 | 1.21872012 |
| 22 | IRAK1 | 1.20524403 |
| 23 | TRIM28 | 1.03894960 |
| 24 | NEK9 | 1.02274502 |
| 25 | MAPK11 | 1.01249215 |
| 26 | MAPKAPK5 | 0.98161948 |
| 27 | MKNK1 | 0.96470627 |
| 28 | RIPK1 | 0.91455253 |
| 29 | CAMK1G | 0.89867481 |
| 30 | TXK | 0.84806980 |
| 31 | WNK3 | 0.81553815 |
| 32 | PRKCI | 0.80109149 |
| 33 | WNK4 | 0.79410729 |
| 34 | CAMK2A | 0.78278680 |
| 35 | OXSR1 | 0.76278243 |
| 36 | MKNK2 | 0.73655418 |
| 37 | BCKDK | 0.73107441 |
| 38 | EPHA4 | 0.66364897 |
| 39 | STK39 | 0.64828992 |
| 40 | GRK7 | 0.64561234 |
| 41 | ERBB2 | 0.57741823 |
| 42 | NTRK2 | 0.56296885 |
| 43 | NEK1 | 0.56046230 |
| 44 | TNIK | 0.54698763 |
| 45 | TEC | 0.54144476 |
| 46 | TAOK3 | 0.51594549 |
| 47 | NUAK1 | 0.50481874 |
| 48 | STK38 | 0.47435781 |
| 49 | CAMK1 | 0.47418638 |
| 50 | NEK2 | 0.47325424 |
| 51 | PRKCB | 0.44321610 |
| 52 | STK3 | 0.43896489 |
| 53 | PRKCA | 0.40590988 |
| 54 | FLT3 | 0.40319362 |
| 55 | CSNK1E | 0.35724689 |
| 56 | SGK1 | 0.35401081 |
| 57 | DYRK1A | 0.35380519 |
| 58 | PTK2B | 0.34289043 |
| 59 | GRK5 | 0.32368323 |
| 60 | STK16 | 0.32051086 |
| 61 | MST4 | 0.31892799 |
| 62 | NEK6 | 0.31539066 |
| 63 | TGFBR2 | 0.31437211 |
| 64 | STK38L | 0.31288968 |
| 65 | CSNK2A2 | 0.31085939 |
| 66 | FGFR2 | 0.30521635 |
| 67 | CAMK4 | 0.29470129 |
| 68 | MAPK1 | 0.29241671 |
| 69 | CSNK1A1 | 0.29183140 |
| 70 | ATR | 0.27169974 |
| 71 | BRSK1 | 0.26503433 |
| 72 | CSNK1A1L | 0.25714749 |
| 73 | RPS6KA3 | 0.25025239 |
| 74 | AKT1 | 0.24974359 |
| 75 | EIF2AK2 | 0.24432893 |
| 76 | PRKACG | 0.24220774 |
| 77 | ATM | 0.23956492 |
| 78 | PRKACA | 0.23770946 |
| 79 | INSRR | 0.23162007 |
| 80 | ABL1 | 0.22525501 |
| 81 | WEE1 | 0.22309855 |
| 82 | BUB1 | 0.22251596 |
| 83 | MAP4K2 | 0.22249970 |
| 84 | VRK1 | 0.21879994 |
| 85 | PDK1 | 0.21643816 |
| 86 | STK10 | 0.20338929 |
| 87 | MAPK13 | 0.19378410 |
| 88 | MAPK3 | 0.19029509 |
| 89 | FGFR1 | 0.17725783 |
| 90 | CSF1R | 0.16792881 |
| 91 | PLK3 | 0.16375725 |
| 92 | ERBB4 | 0.15815718 |
| 93 | CSNK2A1 | 0.15360592 |
| 94 | MELK | 0.15210110 |
| 95 | MATK | 0.14783879 |
| 96 | OBSCN | 0.14478334 |
| 97 | CSNK1G1 | 0.14308959 |
| 98 | TSSK6 | 0.12348449 |
| 99 | GSK3B | 0.11978242 |
| 100 | CSNK1G3 | 0.11427540 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 3.47298516 |
| 2 | Olfactory transduction_Homo sapiens_hsa04740 | 3.29020725 |
| 3 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.09447283 |
| 4 | Phototransduction_Homo sapiens_hsa04744 | 3.07080790 |
| 5 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.92104978 |
| 6 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.84572325 |
| 7 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.69633034 |
| 8 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.48272120 |
| 9 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 2.45790550 |
| 10 | ABC transporters_Homo sapiens_hsa02010 | 2.42146398 |
| 11 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.35179751 |
| 12 | Morphine addiction_Homo sapiens_hsa05032 | 2.30034984 |
| 13 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 2.15045068 |
| 14 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.91923128 |
| 15 | Sulfur relay system_Homo sapiens_hsa04122 | 1.80569553 |
| 16 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.77337641 |
| 17 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.76980982 |
| 18 | Basal transcription factors_Homo sapiens_hsa03022 | 1.71446265 |
| 19 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.63859182 |
| 20 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.51646230 |
| 21 | Taste transduction_Homo sapiens_hsa04742 | 1.50968171 |
| 22 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.50265796 |
| 23 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.47813356 |
| 24 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.47522295 |
| 25 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.42579492 |
| 26 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.40916185 |
| 27 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.39483305 |
| 28 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.35936477 |
| 29 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.35032777 |
| 30 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.31201103 |
| 31 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.27793714 |
| 32 | Homologous recombination_Homo sapiens_hsa03440 | 1.26174423 |
| 33 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.22559211 |
| 34 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.22071621 |
| 35 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.21064323 |
| 36 | Protein export_Homo sapiens_hsa03060 | 1.17612118 |
| 37 | Retinol metabolism_Homo sapiens_hsa00830 | 1.15934893 |
| 38 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.14297581 |
| 39 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.13902476 |
| 40 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.13181483 |
| 41 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.06427386 |
| 42 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.06368849 |
| 43 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.03485639 |
| 44 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.02930707 |
| 45 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.99564909 |
| 46 | RNA degradation_Homo sapiens_hsa03018 | 0.92160922 |
| 47 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.91272425 |
| 48 | Proteasome_Homo sapiens_hsa03050 | 0.90417959 |
| 49 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.89497827 |
| 50 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.89371165 |
| 51 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.87179168 |
| 52 | Mineral absorption_Homo sapiens_hsa04978 | 0.85956134 |
| 53 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.83875985 |
| 54 | Peroxisome_Homo sapiens_hsa04146 | 0.80311567 |
| 55 | Histidine metabolism_Homo sapiens_hsa00340 | 0.77064737 |
| 56 | Salivary secretion_Homo sapiens_hsa04970 | 0.76856793 |
| 57 | Metabolic pathways_Homo sapiens_hsa01100 | 0.75614254 |
| 58 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.75545580 |
| 59 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.73547359 |
| 60 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.72903041 |
| 61 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.69362120 |
| 62 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.65261487 |
| 63 | Parkinsons disease_Homo sapiens_hsa05012 | 0.64568201 |
| 64 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.64533071 |
| 65 | Purine metabolism_Homo sapiens_hsa00230 | 0.63743791 |
| 66 | Asthma_Homo sapiens_hsa05310 | 0.55708851 |
| 67 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.55621654 |
| 68 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.55621380 |
| 69 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.55391104 |
| 70 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.51845285 |
| 71 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.51284279 |
| 72 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.51075058 |
| 73 | Legionellosis_Homo sapiens_hsa05134 | 0.51063216 |
| 74 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.50873827 |
| 75 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.50641674 |
| 76 | Nicotine addiction_Homo sapiens_hsa05033 | 0.50202912 |
| 77 | RNA polymerase_Homo sapiens_hsa03020 | 0.49344264 |
| 78 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.48974250 |
| 79 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.47951634 |
| 80 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.47753168 |
| 81 | Alzheimers disease_Homo sapiens_hsa05010 | 0.46546137 |
| 82 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.46233051 |
| 83 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.45312257 |
| 84 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.44223301 |
| 85 | Huntingtons disease_Homo sapiens_hsa05016 | 0.43408900 |
| 86 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.40224584 |
| 87 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.39499610 |
| 88 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.39435931 |
| 89 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.39233020 |
| 90 | Circadian entrainment_Homo sapiens_hsa04713 | 0.38905390 |
| 91 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.38833068 |
| 92 | Base excision repair_Homo sapiens_hsa03410 | 0.36599866 |
| 93 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.36393594 |
| 94 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.35757108 |
| 95 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.35411876 |
| 96 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.34465896 |
| 97 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.32845393 |
| 98 | RNA transport_Homo sapiens_hsa03013 | 0.30989419 |
| 99 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.29511629 |
| 100 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.27822543 |

